初次膝关节置换术后翻修的估计终生风险受年龄、性别和适应证影响
基于苏格兰关节置换项目1998年1月1日至2019年12月31日接受初次膝关节置换的全部患者,计算20年翻修与死亡的累积发生率,并用多减寿表法估计45至99岁患者的终生翻修风险。估计终生翻修风险从45至49岁患者的32.7%(95%CI 22.6至47.3)降至90岁以上患者的0.6%(95%CI 0.1至4.5)。结论认为终生翻修风险因性别、年龄和基础诊断而异,45至49岁患者终生翻修风险约为三分之一,并随年龄增长降至90岁及以上者的1/159。
要点
- 45至49岁患者初次膝关节置换后估计终生翻修风险为32.7%(95%CI 22.6至47.3)。
- 90岁以上患者估计终生翻修风险为0.6%(95%CI 0.1至4.5)。
- 20年累积翻修发生率为6.8%(95%CI 6.6至7.0),显著低于死亡的66.3%(95%CI 65.4至67.1)。
核心结论
- 估计终生翻修风险因患者性别、年龄和基础诊断而异。
- 45至49岁患者终生接受翻修手术的风险约为三分之一,并随年龄增长降至90岁及以上者的1/159。
研究设计与样本
- 纳入苏格兰关节置换项目数据集1998年1月1日至2019年12月31日期间接受初次膝关节置换的全部患者。
- 计算翻修与死亡的累积发生率函数至20年,调整分析采用病因特异性Cox回归模型确定患者因素的影响。
- 采用多减寿表法计算45至99岁患者的终生风险百分比。
主要发现
- 估计终生翻修风险范围从45至49岁患者的32.7%(95%CI 22.6至47.3)至90岁以上患者的0.6%(95%CI 0.1至4.5)。
- 20年时总体累积翻修发生率为6.8%(95%CI 6.6至7.0),显著低于死亡的66.3%(95%CI 65.4至67.1)。
- 调整分析显示年龄增长对翻修风险(HR 0.5(95%CI 0.5至0.6))与死亡风险(HR 3.6(95%CI 3.4至3.7))呈相反效应。
- 男性与翻修风险(HR 1.1(95%CI 1.1至1.2);p < 0.001)和死亡风险(HR 1.4(95%CI 1.3至1.4);p < 0.001)增加相关。
- 与因骨关节炎行初次膝关节置换的患者相比,炎性关节病患者死亡风险更高(HR 1.7(95%CI 1.7至1.8);p < 0.001),但翻修可能性更低(HR 0.9(95%CI 0.7至1.0);p < 0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to assess factors associated with the estimated lifetime risk of revision surgery after primary knee arthroplasty (KA). METHODS: All patients from the Scottish Arthroplasty Project dataset undergoing primary KA during the period 1 January 1998 to 31 December 2019 were included. The cumulative incidence function for revision and death was calculated up to 20 years. Adjusted analyses used cause-specific Cox regression modelling to determine the influence of patient factors. The lifetime risk was calculated as a percentage for patients aged between 45 and 99 years using multiple-decrement life table methodology. RESULTS: The estimated lifetime risk of revision ranged between 32.7% (95% confidence interval (CI) 22.6 to 47.3) for patients aged 45 to 49 years and 0.6% (95% CI 0.1 to 4.5) for patients aged over 90 years. At 20 years, the overall cumulative incidence of revision (6.8% (95% CI 6.6 to 7.0)) was significantly less than that of death (66.3% (95% CI 65.4 to 67.1)). Adjusted analyses demonstrated converse effect of increasing age on risk of revision (hazard ratio (HR) 0.5 (95% CI 0.5 to 0.6)) and death (HR 3.6 (95% CI 3.4 to 3.7)). Male sex was associated with increased risks of revision (HR 1.1 (95% CI 1.1 to 1.2); p < 0.001) and death (HR 1.4 (95% CI 1.3 to 1.4); p < 0.001). Compared to patients undergoing primary KA for osteoarthritis, patients with inflammatory arthropathy had a higher risk of death (HR 1.7 (95% CI 1.7 to 1.8); p < 0.001), but were less likely to be revised (HR 0.9 (95% CI 0.7 to 1.0); p < 0.001). Patients with a greater number of comorbidities (HR 1.4 (95% CI 1.3 to 1.4)) and greater levels of socioeconomic deprivation (HR 1.4 (95% CI 1.4 to 1.5)) were at increased risk of death, but neither increased the risk of revision. CONCLUSION: The estimated lifetime risk of revision KA varied depending on patient sex, age, and underlying diagnosis. Patients aged between 45 and 49 years had a one in three risk of undergoing revision surgery within their lifetime, which decreased with age to one in 159 in those aged 90 years or more.Cite this article: Bone Joint J 2022;104-B(12):1313-1322.
引用
- Yapp LZ, Clement ND, Moran M, et al. The estimated lifetime risk of revision after primary knee arthroplasty is influenced by age, sex, and indication. Bone Joint J. 2022. PMID: 36453048. doi:10.1302/0301-620X.104B12.BJJ-2021-1631.R3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。